Glass House Brands hits its June 18 earnings release having already moved decisively in bulls' favour, with the stock up 35% over the past month to $13.09 — making the print a test of whether the fundamentals justify the run.
The borrow market confirms the bear retreat is real. Cost to borrow has fallen from a peak near 7.5% in early May to 1.56% today — a collapse of more than 75% in six weeks. Short interest dropped in parallel, shedding 43% over the month to roughly 85,000 shares, or just 0.12% of float. Availability is effectively unlimited, with nearly 9.8 million shares available to borrow against a tiny short book. There is no squeeze dynamic here, no forced covering pressure, and no meaningful bearish overhang to unwind into the print.
The ownership picture adds texture to the bull side. AdvisorShares holds 8.7% of shares, the largest institutional block, with a position added in full as recently as May. Co-founders Kyle Kazan and Graham Farrar each added shares in early June through equity awards — though both also made modest open-market sales around the same time at prices near $11–12, well below today's $13.09. The net insider flow over 90 days is positive at roughly $1.7m, skewed heavily by award grants rather than outright purchases. The pattern suggests insiders are participating in the stock's rise rather than aggressively pressing new bets. One counterpoint: Mercer Park trimmed its position by more than 1.4 million shares in the most recent reporting period, a reduction worth watching given the fund's historical involvement in cannabis names.
The most recent earnings print, from May 13, saw the stock gain 7.7% on the day and extend to nearly 9.5% over the following five days — a clean positive reaction that set the stage for the month-long rally now in the price. With ORTEX factor scores placing GLAS.F in the 81st percentile for EPS surprise and the 91st for short score rank, the data-driven setup looks constructive. Analyst coverage remains sparse and the only formal price target on record — $10.25, with a mean based on stale data — now sits well below the current price, leaving valuation a largely open question. The EV/EBITDA multiple of 17.5x is the most concrete anchor available, and it has held relatively steady over the past month.
Today's print will test whether the operational execution — particularly California cultivation economics and any regulatory commentary — can sustain a stock that has already priced in a considerable degree of optimism.
See the live data behind this article on ORTEX.
Open GLAS.F on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
